Lila Sciences
Founded in 2023, Lila Sciences develops a scientific superintelligence platform and autonomous lab for life, chemistry, and materials science.
Secondary Market Price
How Lila Sciences Measures Up
To help you manage your Lila Sciences equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series A
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Lila Sciences's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Lila Sciences Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Lila Sciences's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Lila Sciences, founded in 2023, is developing a scientific superintelligence platform and an autonomous laboratory focused on life sciences, chemistry, and materials science. The company's approach involves applying artificial intelligence to the scientific method, utilizing AI agents to design, conduct, and analyze physical experiments in a closed loop. A Flagship Pioneering company, Lila Sciences raised $115 million in a Series A funding round in November 2025 and has grown to a team of between 201 and 500 employees. The company's stated goal is to accelerate discovery in areas such as human health and sustainability.
The company plans to continue scaling its platform and is actively hiring to expand its team. Recent activities include participation in industry events such as JPM26 and NeurIPS, where team members engaged with the scientific and AI communities. Company leadership has also spoken at events like the J.P. Morgan Healthcare Conference on the topic of AI in drug discovery. Lila Sciences utilizes tools from NVIDIA and infrastructure from AWS to support its large-scale computational work, and has highlighted these technical collaborations in company communications.
- Flagship Pioneering
- General Catalyst
- March Capital
- Altitude Life Science Ventures
- Alumni Ventures
- ARK Venture Fund
- Modi Ventures
- State of Michigan Retirement System
- Abu Dhabi Investment Authority
- Braidwell
- Collective Global
- NVentures
- Analog Devices
- IQT
- Dauntless Ventures
- Catalio Capital Management
- Pennant Investors
- Peter Diamandis’ Abundance Membership
- Co-Founder, Geoffrey von Maltzahn
- Co-Founder, Noubar Afeyan
- Co-Founder, Molly Gibson
- Co-Founder, Alexandra Sneider
- Co-Founder, Jacob Feala
- Co-Founder, Scott Robertson
- Co-Founder, Ben Kompa
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Lila Sciences worth joining?
Deciding whether to join a startup like Lila Sciences involves evaluating its growth potential and how its equity compensation fits into your financial goals. Tools like Prospect can help you model the potential value of your equity package to make a more informed career decision.
What should I do with my Lila Sciences stock?
Managing your Lila Sciences equity requires a strategy for exercising options and planning for taxes to maximize your potential returns. Prospect offers personalized strategies to help you decide when to exercise and how to minimize your tax burden.
Can you sell Lila Sciences stock?
As Lila Sciences is a private company, its stock is not publicly traded and can be difficult to sell. Platforms like Prospect provide tools to help you navigate opportunities like tender offers or secondary market sales in a tax-optimal way.
How can I find the value of my Lila Sciences stock?
The value of private stock like Lila Sciences' isn't always clear, as it doesn't trade on a public market. Prospect uses proprietary predictive models and secondary market data to help you project the future value of your shares.
What is Lila Sciences's equity worth?
The exact worth of Lila Sciences's equity fluctuates and depends on factors like its latest valuation and future growth prospects. You can use Prospect's platform to model different scenarios and get a clearer picture of your equity's potential post-tax value.
What is Lila Sciences's stock ticker symbol?
Since Lila Sciences is a private company, it does not have a stock ticker symbol and is not listed on a public stock exchange. You can track its valuation and your equity's potential through specialized platforms designed for private company stock.
Can I buy or sell Lila Sciences stock?
Buying shares is typically done by exercising stock options you've been granted, while selling is limited to specific events like tender offers. Prospect can help you create a strategy for both exercising your options and selling your shares when the time is right.
What is the criteria to buy or invest in Lila Sciences stock?
For employees, the primary way to acquire stock is by exercising options granted as part of your compensation package. Understanding the financial implications, such as the cost to exercise and the associated taxes, is a critical step that platforms like Prospect can help with.
